| 摘要 |
The object of the present invention is to provide a T cell line capable of continuously producing human immunodeficiency virus (HIV) using CC chemokine receptor 5 (CCR5); and being in a state of continuously producing human immunodeficiency virus (HIV) or in a state wherein human immunodeficiency virus (HIV) is latently infecting, and a method for isolating and producing the T cell line. The present invention related to T cell line capable continuously producing human immunodeficiency virus (HIV) using cc chemokine receptor 5 (CCR5) and being in a state of continuously producing human immunodeficiency virus (HIV) is latently infecting, a method for screenings by use of the T cell line of (1) HIV resistant to an agent having an anti-HIV activity, (2) an agent having an anti-HIV activity, (3) an agent inhibiting the transition of HIV from the latent period into the proliferation period, and (4) an agent capable of eliminating HIV from T cell line; and a pharmaceutical composition comprising the agent obtained by the above screenings of (2) to (4). A T cell line of the present invention having a continuous productivity of human immunodeficiency virus (HIV) usnig CC Chemokine receptor 5 (CCR5) is useful in screening for agents or salts thereof for the treatment or prevention of diseases such as AIDS caused by HIV. |
